nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabazitaxel—ABCB1—colon cancer	0.163	1	CbGaD
Cabazitaxel—TUBA4A—Vincristine—colon cancer	0.121	0.176	CbGbCtD
Cabazitaxel—TUBB8—Vincristine—colon cancer	0.0552	0.0803	CbGbCtD
Cabazitaxel—TUBB4A—Vincristine—colon cancer	0.0552	0.0803	CbGbCtD
Cabazitaxel—TUBB2B—Vincristine—colon cancer	0.0552	0.0803	CbGbCtD
Cabazitaxel—TUBB3—Vincristine—colon cancer	0.0552	0.0803	CbGbCtD
Cabazitaxel—TUBB2A—Vincristine—colon cancer	0.0552	0.0803	CbGbCtD
Cabazitaxel—TUBB6—Vincristine—colon cancer	0.0552	0.0803	CbGbCtD
Cabazitaxel—TUBB4B—Vincristine—colon cancer	0.0462	0.0672	CbGbCtD
Cabazitaxel—TUBB1—Vincristine—colon cancer	0.0462	0.0672	CbGbCtD
Cabazitaxel—TUBB—Vincristine—colon cancer	0.0462	0.0672	CbGbCtD
Cabazitaxel—SLCO1B1—Irinotecan—colon cancer	0.0131	0.0191	CbGbCtD
Cabazitaxel—SLCO1B3—Methotrexate—colon cancer	0.0119	0.0174	CbGbCtD
Cabazitaxel—ABCG2—Irinotecan—colon cancer	0.0104	0.0152	CbGbCtD
Cabazitaxel—ABCG2—Fluorouracil—colon cancer	0.01	0.0146	CbGbCtD
Cabazitaxel—ABCG2—Vincristine—colon cancer	0.00912	0.0133	CbGbCtD
Cabazitaxel—SLCO1B1—Methotrexate—colon cancer	0.00695	0.0101	CbGbCtD
Cabazitaxel—CYP3A5—Irinotecan—colon cancer	0.00578	0.00841	CbGbCtD
Cabazitaxel—ABCG2—Methotrexate—colon cancer	0.00552	0.00803	CbGbCtD
Cabazitaxel—CYP2C8—Fluorouracil—colon cancer	0.00533	0.00776	CbGbCtD
Cabazitaxel—CYP3A5—Vincristine—colon cancer	0.00505	0.00735	CbGbCtD
Cabazitaxel—ABCB1—Irinotecan—colon cancer	0.00376	0.00547	CbGbCtD
Cabazitaxel—ABCB1—Vincristine—colon cancer	0.00329	0.00478	CbGbCtD
Cabazitaxel—CYP3A4—Irinotecan—colon cancer	0.00225	0.00328	CbGbCtD
Cabazitaxel—ABCB1—Methotrexate—colon cancer	0.00199	0.0029	CbGbCtD
Cabazitaxel—CYP3A4—Vincristine—colon cancer	0.00197	0.00287	CbGbCtD
Cabazitaxel—Docetaxel—EGFR—colon cancer	0.00167	0.622	CrCbGaD
Cabazitaxel—TUBB3—lymphoid tissue—colon cancer	0.00104	0.0265	CbGeAlD
Cabazitaxel—TUBB3—digestive system—colon cancer	0.00103	0.0262	CbGeAlD
Cabazitaxel—TUBA4A—epithelium—colon cancer	0.00102	0.0262	CbGeAlD
Cabazitaxel—TUBB4A—embryo—colon cancer	0.00101	0.0257	CbGeAlD
Cabazitaxel—TUBA4A—smooth muscle tissue—colon cancer	0.000988	0.0252	CbGeAlD
Cabazitaxel—TUBA4A—renal system—colon cancer	0.000951	0.0243	CbGeAlD
Cabazitaxel—TUBB1—bone marrow—colon cancer	0.000926	0.0236	CbGeAlD
Cabazitaxel—SLCO1B3—vagina—colon cancer	0.000794	0.0203	CbGeAlD
Cabazitaxel—TUBA4A—lymphoid tissue—colon cancer	0.000789	0.0202	CbGeAlD
Cabazitaxel—TUBB4B—embryo—colon cancer	0.000785	0.02	CbGeAlD
Cabazitaxel—TUBA4A—digestive system—colon cancer	0.00078	0.0199	CbGeAlD
Cabazitaxel—TUBB4A—renal system—colon cancer	0.000762	0.0195	CbGeAlD
Cabazitaxel—TUBB6—epithelium—colon cancer	0.000737	0.0188	CbGeAlD
Cabazitaxel—TUBB2B—renal system—colon cancer	0.000736	0.0188	CbGeAlD
Cabazitaxel—TUBB—smooth muscle tissue—colon cancer	0.000724	0.0185	CbGeAlD
Cabazitaxel—TUBB2A—smooth muscle tissue—colon cancer	0.00072	0.0184	CbGeAlD
Cabazitaxel—TUBA4A—bone marrow—colon cancer	0.000719	0.0184	CbGeAlD
Cabazitaxel—TUBB6—smooth muscle tissue—colon cancer	0.00071	0.0181	CbGeAlD
Cabazitaxel—TUBA4A—vagina—colon cancer	0.000689	0.0176	CbGeAlD
Cabazitaxel—TUBB6—renal system—colon cancer	0.000684	0.0175	CbGeAlD
Cabazitaxel—SLCO1B3—liver—colon cancer	0.00067	0.0171	CbGeAlD
Cabazitaxel—SLCO1B1—renal system—colon cancer	0.000634	0.0162	CbGeAlD
Cabazitaxel—TUBB4A—lymphoid tissue—colon cancer	0.000633	0.0162	CbGeAlD
Cabazitaxel—TUBB4A—digestive system—colon cancer	0.000625	0.016	CbGeAlD
Cabazitaxel—TUBB4B—smooth muscle tissue—colon cancer	0.000617	0.0158	CbGeAlD
Cabazitaxel—TUBB2B—digestive system—colon cancer	0.000604	0.0154	CbGeAlD
Cabazitaxel—TUBB4B—renal system—colon cancer	0.000594	0.0152	CbGeAlD
Cabazitaxel—TUBA4A—liver—colon cancer	0.000581	0.0148	CbGeAlD
Cabazitaxel—TUBB2A—digestive system—colon cancer	0.000568	0.0145	CbGeAlD
Cabazitaxel—TUBB6—lymphoid tissue—colon cancer	0.000568	0.0145	CbGeAlD
Cabazitaxel—TUBB6—digestive system—colon cancer	0.000561	0.0143	CbGeAlD
Cabazitaxel—TUBB2B—vagina—colon cancer	0.000533	0.0136	CbGeAlD
Cabazitaxel—TUBB—bone marrow—colon cancer	0.000527	0.0135	CbGeAlD
Cabazitaxel—TUBB2A—bone marrow—colon cancer	0.000524	0.0134	CbGeAlD
Cabazitaxel—SLCO1B1—digestive system—colon cancer	0.00052	0.0133	CbGeAlD
Cabazitaxel—TUBB6—bone marrow—colon cancer	0.000517	0.0132	CbGeAlD
Cabazitaxel—Paclitaxel—ABCB1—colon cancer	0.000507	0.189	CrCbGaD
Cabazitaxel—Docetaxel—ABCB1—colon cancer	0.000507	0.189	CrCbGaD
Cabazitaxel—TUBB—vagina—colon cancer	0.000505	0.0129	CbGeAlD
Cabazitaxel—TUBB2A—vagina—colon cancer	0.000502	0.0128	CbGeAlD
Cabazitaxel—TUBB6—vagina—colon cancer	0.000495	0.0126	CbGeAlD
Cabazitaxel—TUBB4B—lymphoid tissue—colon cancer	0.000493	0.0126	CbGeAlD
Cabazitaxel—TUBB4B—digestive system—colon cancer	0.000487	0.0124	CbGeAlD
Cabazitaxel—TUBB4A—liver—colon cancer	0.000466	0.0119	CbGeAlD
Cabazitaxel—TUBB4B—bone marrow—colon cancer	0.000449	0.0115	CbGeAlD
Cabazitaxel—TUBA4A—lymph node—colon cancer	0.000445	0.0114	CbGeAlD
Cabazitaxel—TUBB4B—vagina—colon cancer	0.00043	0.011	CbGeAlD
Cabazitaxel—TUBB—liver—colon cancer	0.000426	0.0109	CbGeAlD
Cabazitaxel—TUBB2A—liver—colon cancer	0.000424	0.0108	CbGeAlD
Cabazitaxel—TUBB6—liver—colon cancer	0.000418	0.0107	CbGeAlD
Cabazitaxel—SLCO1B1—liver—colon cancer	0.000387	0.00989	CbGeAlD
Cabazitaxel—ABCB1—blood vessel—colon cancer	0.000383	0.00977	CbGeAlD
Cabazitaxel—TUBB4B—liver—colon cancer	0.000363	0.00927	CbGeAlD
Cabazitaxel—CYP2C8—renal system—colon cancer	0.00036	0.0092	CbGeAlD
Cabazitaxel—TUBB4A—lymph node—colon cancer	0.000357	0.00911	CbGeAlD
Cabazitaxel—TUBB2B—lymph node—colon cancer	0.000345	0.00881	CbGeAlD
Cabazitaxel—TUBB—lymph node—colon cancer	0.000326	0.00834	CbGeAlD
Cabazitaxel—CYP3A5—renal system—colon cancer	0.000325	0.00831	CbGeAlD
Cabazitaxel—TUBB2A—lymph node—colon cancer	0.000325	0.00829	CbGeAlD
Cabazitaxel—TUBB6—lymph node—colon cancer	0.00032	0.00818	CbGeAlD
Cabazitaxel—TUBB4B—lymph node—colon cancer	0.000278	0.00711	CbGeAlD
Cabazitaxel—CYP3A5—digestive system—colon cancer	0.000267	0.00681	CbGeAlD
Cabazitaxel—ABCG2—bone marrow—colon cancer	0.000265	0.00677	CbGeAlD
Cabazitaxel—CYP2C8—vagina—colon cancer	0.000261	0.00667	CbGeAlD
Cabazitaxel—ABCG2—vagina—colon cancer	0.000254	0.00648	CbGeAlD
Cabazitaxel—CYP3A4—renal system—colon cancer	0.000244	0.00623	CbGeAlD
Cabazitaxel—CYP3A5—vagina—colon cancer	0.000236	0.00602	CbGeAlD
Cabazitaxel—ABCB1—embryo—colon cancer	0.000228	0.00583	CbGeAlD
Cabazitaxel—CYP2C8—liver—colon cancer	0.00022	0.00562	CbGeAlD
Cabazitaxel—Arrhythmia—Irinotecan—colon cancer	0.000217	0.00222	CcSEcCtD
Cabazitaxel—Dry skin—Capecitabine—colon cancer	0.000215	0.0022	CcSEcCtD
Cabazitaxel—Alopecia—Irinotecan—colon cancer	0.000214	0.00219	CcSEcCtD
Cabazitaxel—Orthostatic hypotension—Capecitabine—colon cancer	0.000214	0.00219	CcSEcCtD
Cabazitaxel—Abdominal pain upper—Capecitabine—colon cancer	0.000214	0.00219	CcSEcCtD
Cabazitaxel—ABCG2—liver—colon cancer	0.000214	0.00547	CbGeAlD
Cabazitaxel—Hypokalaemia—Capecitabine—colon cancer	0.000214	0.00218	CcSEcCtD
Cabazitaxel—Breast disorder—Capecitabine—colon cancer	0.000212	0.00217	CcSEcCtD
Cabazitaxel—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.000211	0.00216	CcSEcCtD
Cabazitaxel—Back pain—Vincristine—colon cancer	0.00021	0.00214	CcSEcCtD
Cabazitaxel—Sepsis—Methotrexate—colon cancer	0.000209	0.00214	CcSEcCtD
Cabazitaxel—Gastritis—Capecitabine—colon cancer	0.000208	0.00212	CcSEcCtD
Cabazitaxel—Arrhythmia—Fluorouracil—colon cancer	0.000208	0.00212	CcSEcCtD
Cabazitaxel—Alanine aminotransferase increased—Capecitabine—colon cancer	0.000207	0.00212	CcSEcCtD
Cabazitaxel—Alopecia—Fluorouracil—colon cancer	0.000205	0.0021	CcSEcCtD
Cabazitaxel—Back pain—Irinotecan—colon cancer	0.000204	0.00209	CcSEcCtD
Cabazitaxel—Abdominal distension—Capecitabine—colon cancer	0.000204	0.00209	CcSEcCtD
Cabazitaxel—Muscle spasms—Irinotecan—colon cancer	0.000203	0.00208	CcSEcCtD
Cabazitaxel—Influenza—Capecitabine—colon cancer	0.000203	0.00207	CcSEcCtD
Cabazitaxel—Erythema—Fluorouracil—colon cancer	0.000202	0.00207	CcSEcCtD
Cabazitaxel—Anaemia—Vincristine—colon cancer	0.0002	0.00205	CcSEcCtD
Cabazitaxel—CYP3A4—digestive system—colon cancer	0.0002	0.00511	CbGeAlD
Cabazitaxel—CYP3A5—liver—colon cancer	0.000199	0.00508	CbGeAlD
Cabazitaxel—Ill-defined disorder—Irinotecan—colon cancer	0.000196	0.002	CcSEcCtD
Cabazitaxel—Anaemia—Irinotecan—colon cancer	0.000195	0.002	CcSEcCtD
Cabazitaxel—Vertigo—Vincristine—colon cancer	0.000195	0.00199	CcSEcCtD
Cabazitaxel—Leukopenia—Vincristine—colon cancer	0.000194	0.00198	CcSEcCtD
Cabazitaxel—Malaise—Irinotecan—colon cancer	0.00019	0.00195	CcSEcCtD
Cabazitaxel—Vertigo—Irinotecan—colon cancer	0.00019	0.00194	CcSEcCtD
Cabazitaxel—Neutropenia—Capecitabine—colon cancer	0.00019	0.00194	CcSEcCtD
Cabazitaxel—Dysuria—Capecitabine—colon cancer	0.00019	0.00194	CcSEcCtD
Cabazitaxel—Renal failure acute—Methotrexate—colon cancer	0.000189	0.00194	CcSEcCtD
Cabazitaxel—Leukopenia—Irinotecan—colon cancer	0.000189	0.00193	CcSEcCtD
Cabazitaxel—Upper respiratory tract infection—Capecitabine—colon cancer	0.000189	0.00193	CcSEcCtD
Cabazitaxel—Hypertension—Vincristine—colon cancer	0.000187	0.00191	CcSEcCtD
Cabazitaxel—Anaemia—Fluorouracil—colon cancer	0.000187	0.00191	CcSEcCtD
Cabazitaxel—ABCB1—epithelium—colon cancer	0.000186	0.00476	CbGeAlD
Cabazitaxel—Myalgia—Vincristine—colon cancer	0.000185	0.00189	CcSEcCtD
Cabazitaxel—Cough—Irinotecan—colon cancer	0.000184	0.00188	CcSEcCtD
Cabazitaxel—Weight decreased—Capecitabine—colon cancer	0.000184	0.00188	CcSEcCtD
Cabazitaxel—Hyperglycaemia—Capecitabine—colon cancer	0.000183	0.00187	CcSEcCtD
Cabazitaxel—Hypertension—Irinotecan—colon cancer	0.000182	0.00186	CcSEcCtD
Cabazitaxel—Pneumonia—Capecitabine—colon cancer	0.000182	0.00186	CcSEcCtD
Cabazitaxel—Leukopenia—Fluorouracil—colon cancer	0.000181	0.00185	CcSEcCtD
Cabazitaxel—Infestation NOS—Capecitabine—colon cancer	0.000181	0.00185	CcSEcCtD
Cabazitaxel—Infestation—Capecitabine—colon cancer	0.000181	0.00185	CcSEcCtD
Cabazitaxel—Lethargy—Methotrexate—colon cancer	0.000178	0.00182	CcSEcCtD
Cabazitaxel—Renal failure—Capecitabine—colon cancer	0.000178	0.00182	CcSEcCtD
Cabazitaxel—Discomfort—Irinotecan—colon cancer	0.000178	0.00182	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Capecitabine—colon cancer	0.000177	0.00181	CcSEcCtD
Cabazitaxel—Oedema—Vincristine—colon cancer	0.000177	0.00181	CcSEcCtD
Cabazitaxel—Infection—Vincristine—colon cancer	0.000176	0.0018	CcSEcCtD
Cabazitaxel—Conjunctivitis—Capecitabine—colon cancer	0.000176	0.0018	CcSEcCtD
Cabazitaxel—Urinary tract infection—Capecitabine—colon cancer	0.000176	0.0018	CcSEcCtD
Cabazitaxel—Confusional state—Irinotecan—colon cancer	0.000174	0.00178	CcSEcCtD
Cabazitaxel—Nervous system disorder—Vincristine—colon cancer	0.000174	0.00177	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Vincristine—colon cancer	0.000173	0.00177	CcSEcCtD
Cabazitaxel—ABCB1—renal system—colon cancer	0.000173	0.00441	CbGeAlD
Cabazitaxel—Haematuria—Capecitabine—colon cancer	0.000172	0.00176	CcSEcCtD
Cabazitaxel—Oedema—Irinotecan—colon cancer	0.000172	0.00176	CcSEcCtD
Cabazitaxel—Myalgia—Fluorouracil—colon cancer	0.000172	0.00176	CcSEcCtD
Cabazitaxel—Chest pain—Fluorouracil—colon cancer	0.000172	0.00176	CcSEcCtD
Cabazitaxel—Infection—Irinotecan—colon cancer	0.000171	0.00175	CcSEcCtD
Cabazitaxel—Discomfort—Fluorouracil—colon cancer	0.00017	0.00174	CcSEcCtD
Cabazitaxel—Nervous system disorder—Irinotecan—colon cancer	0.000169	0.00173	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Irinotecan—colon cancer	0.000169	0.00173	CcSEcCtD
Cabazitaxel—Anorexia—Vincristine—colon cancer	0.000169	0.00173	CcSEcCtD
Cabazitaxel—Confusional state—Fluorouracil—colon cancer	0.000166	0.0017	CcSEcCtD
Cabazitaxel—Hypotension—Vincristine—colon cancer	0.000165	0.00169	CcSEcCtD
Cabazitaxel—Oedema—Fluorouracil—colon cancer	0.000165	0.00169	CcSEcCtD
Cabazitaxel—Anorexia—Irinotecan—colon cancer	0.000164	0.00168	CcSEcCtD
Cabazitaxel—ABCG2—lymph node—colon cancer	0.000164	0.00419	CbGeAlD
Cabazitaxel—Infection—Fluorouracil—colon cancer	0.000164	0.00168	CcSEcCtD
Cabazitaxel—Nervous system disorder—Fluorouracil—colon cancer	0.000162	0.00166	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Fluorouracil—colon cancer	0.000162	0.00165	CcSEcCtD
Cabazitaxel—Hypoaesthesia—Capecitabine—colon cancer	0.000162	0.00165	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Vincristine—colon cancer	0.000161	0.00165	CcSEcCtD
Cabazitaxel—Tachycardia—Fluorouracil—colon cancer	0.000161	0.00165	CcSEcCtD
Cabazitaxel—Hypotension—Irinotecan—colon cancer	0.000161	0.00165	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Capecitabine—colon cancer	0.00016	0.00164	CcSEcCtD
Cabazitaxel—Oedema peripheral—Capecitabine—colon cancer	0.00016	0.00164	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Capecitabine—colon cancer	0.00016	0.00163	CcSEcCtD
Cabazitaxel—Urethral disorder—Capecitabine—colon cancer	0.000159	0.00163	CcSEcCtD
Cabazitaxel—Paraesthesia—Vincristine—colon cancer	0.000159	0.00163	CcSEcCtD
Cabazitaxel—Breast disorder—Methotrexate—colon cancer	0.000158	0.00161	CcSEcCtD
Cabazitaxel—Anorexia—Fluorouracil—colon cancer	0.000157	0.00161	CcSEcCtD
Cabazitaxel—Paraesthesia—Irinotecan—colon cancer	0.000155	0.00158	CcSEcCtD
Cabazitaxel—Hypotension—Fluorouracil—colon cancer	0.000154	0.00158	CcSEcCtD
Cabazitaxel—Decreased appetite—Vincristine—colon cancer	0.000154	0.00157	CcSEcCtD
Cabazitaxel—Dyspnoea—Irinotecan—colon cancer	0.000154	0.00157	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Vincristine—colon cancer	0.000153	0.00156	CcSEcCtD
Cabazitaxel—Fatigue—Vincristine—colon cancer	0.000153	0.00156	CcSEcCtD
Cabazitaxel—Eye disorder—Capecitabine—colon cancer	0.000152	0.00155	CcSEcCtD
Cabazitaxel—Dyspepsia—Irinotecan—colon cancer	0.000152	0.00155	CcSEcCtD
Cabazitaxel—Tinnitus—Capecitabine—colon cancer	0.000151	0.00155	CcSEcCtD
Cabazitaxel—Constipation—Vincristine—colon cancer	0.000151	0.00155	CcSEcCtD
Cabazitaxel—Pain—Vincristine—colon cancer	0.000151	0.00155	CcSEcCtD
Cabazitaxel—Cardiac disorder—Capecitabine—colon cancer	0.000151	0.00154	CcSEcCtD
Cabazitaxel—Flushing—Capecitabine—colon cancer	0.000151	0.00154	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00015	0.00154	CcSEcCtD
Cabazitaxel—Decreased appetite—Irinotecan—colon cancer	0.00015	0.00153	CcSEcCtD
Cabazitaxel—CYP3A4—liver—colon cancer	0.000149	0.00381	CbGeAlD
Cabazitaxel—Gastrointestinal disorder—Irinotecan—colon cancer	0.000149	0.00152	CcSEcCtD
Cabazitaxel—Fatigue—Irinotecan—colon cancer	0.000149	0.00152	CcSEcCtD
Cabazitaxel—Paraesthesia—Fluorouracil—colon cancer	0.000148	0.00152	CcSEcCtD
Cabazitaxel—Constipation—Irinotecan—colon cancer	0.000147	0.00151	CcSEcCtD
Cabazitaxel—Pain—Irinotecan—colon cancer	0.000147	0.00151	CcSEcCtD
Cabazitaxel—Angiopathy—Capecitabine—colon cancer	0.000147	0.00151	CcSEcCtD
Cabazitaxel—Dyspnoea—Fluorouracil—colon cancer	0.000147	0.0015	CcSEcCtD
Cabazitaxel—Immune system disorder—Capecitabine—colon cancer	0.000147	0.0015	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Capecitabine—colon cancer	0.000146	0.0015	CcSEcCtD
Cabazitaxel—Chills—Capecitabine—colon cancer	0.000146	0.00149	CcSEcCtD
Cabazitaxel—Dyspepsia—Fluorouracil—colon cancer	0.000145	0.00149	CcSEcCtD
Cabazitaxel—Arrhythmia—Capecitabine—colon cancer	0.000145	0.00148	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Vincristine—colon cancer	0.000145	0.00148	CcSEcCtD
Cabazitaxel—Decreased appetite—Fluorouracil—colon cancer	0.000144	0.00147	CcSEcCtD
Cabazitaxel—Alopecia—Capecitabine—colon cancer	0.000144	0.00147	CcSEcCtD
Cabazitaxel—ABCB1—lymphoid tissue—colon cancer	0.000144	0.00366	CbGeAlD
Cabazitaxel—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000143	0.00146	CcSEcCtD
Cabazitaxel—Mental disorder—Capecitabine—colon cancer	0.000142	0.00145	CcSEcCtD
Cabazitaxel—Feeling abnormal—Irinotecan—colon cancer	0.000142	0.00145	CcSEcCtD
Cabazitaxel—ABCB1—digestive system—colon cancer	0.000142	0.00362	CbGeAlD
Cabazitaxel—Malnutrition—Capecitabine—colon cancer	0.000141	0.00145	CcSEcCtD
Cabazitaxel—Erythema—Capecitabine—colon cancer	0.000141	0.00145	CcSEcCtD
Cabazitaxel—Neutropenia—Methotrexate—colon cancer	0.000141	0.00144	CcSEcCtD
Cabazitaxel—Dysuria—Methotrexate—colon cancer	0.000141	0.00144	CcSEcCtD
Cabazitaxel—Pain—Fluorouracil—colon cancer	0.000141	0.00144	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Irinotecan—colon cancer	0.000141	0.00144	CcSEcCtD
Cabazitaxel—Upper respiratory tract infection—Methotrexate—colon cancer	0.00014	0.00144	CcSEcCtD
Cabazitaxel—Body temperature increased—Vincristine—colon cancer	0.00014	0.00143	CcSEcCtD
Cabazitaxel—Abdominal pain—Vincristine—colon cancer	0.00014	0.00143	CcSEcCtD
Cabazitaxel—Dysgeusia—Capecitabine—colon cancer	0.000138	0.00142	CcSEcCtD
Cabazitaxel—Back pain—Capecitabine—colon cancer	0.000137	0.0014	CcSEcCtD
Cabazitaxel—Body temperature increased—Irinotecan—colon cancer	0.000136	0.00139	CcSEcCtD
Cabazitaxel—Abdominal pain—Irinotecan—colon cancer	0.000136	0.00139	CcSEcCtD
Cabazitaxel—Feeling abnormal—Fluorouracil—colon cancer	0.000136	0.00139	CcSEcCtD
Cabazitaxel—Muscle spasms—Capecitabine—colon cancer	0.000136	0.00139	CcSEcCtD
Cabazitaxel—Pneumonia—Methotrexate—colon cancer	0.000135	0.00138	CcSEcCtD
Cabazitaxel—Infestation NOS—Methotrexate—colon cancer	0.000135	0.00138	CcSEcCtD
Cabazitaxel—Infestation—Methotrexate—colon cancer	0.000135	0.00138	CcSEcCtD
Cabazitaxel—Renal failure—Methotrexate—colon cancer	0.000132	0.00135	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Capecitabine—colon cancer	0.000131	0.00134	CcSEcCtD
Cabazitaxel—Conjunctivitis—Methotrexate—colon cancer	0.000131	0.00134	CcSEcCtD
Cabazitaxel—Anaemia—Capecitabine—colon cancer	0.000131	0.00134	CcSEcCtD
Cabazitaxel—ABCB1—bone marrow—colon cancer	0.000131	0.00334	CbGeAlD
Cabazitaxel—Body temperature increased—Fluorouracil—colon cancer	0.000131	0.00133	CcSEcCtD
Cabazitaxel—Hypersensitivity—Vincristine—colon cancer	0.00013	0.00133	CcSEcCtD
Cabazitaxel—Haematuria—Methotrexate—colon cancer	0.000128	0.00131	CcSEcCtD
Cabazitaxel—Malaise—Capecitabine—colon cancer	0.000127	0.0013	CcSEcCtD
Cabazitaxel—Vertigo—Capecitabine—colon cancer	0.000127	0.0013	CcSEcCtD
Cabazitaxel—Hypersensitivity—Irinotecan—colon cancer	0.000127	0.0013	CcSEcCtD
Cabazitaxel—Asthenia—Vincristine—colon cancer	0.000127	0.0013	CcSEcCtD
Cabazitaxel—Leukopenia—Capecitabine—colon cancer	0.000127	0.00129	CcSEcCtD
Cabazitaxel—ABCB1—vagina—colon cancer	0.000125	0.0032	CbGeAlD
Cabazitaxel—Asthenia—Irinotecan—colon cancer	0.000124	0.00126	CcSEcCtD
Cabazitaxel—Cough—Capecitabine—colon cancer	0.000123	0.00126	CcSEcCtD
Cabazitaxel—Hypertension—Capecitabine—colon cancer	0.000122	0.00125	CcSEcCtD
Cabazitaxel—Hypersensitivity—Fluorouracil—colon cancer	0.000122	0.00124	CcSEcCtD
Cabazitaxel—Diarrhoea—Vincristine—colon cancer	0.000121	0.00124	CcSEcCtD
Cabazitaxel—Arthralgia—Capecitabine—colon cancer	0.00012	0.00123	CcSEcCtD
Cabazitaxel—Chest pain—Capecitabine—colon cancer	0.00012	0.00123	CcSEcCtD
Cabazitaxel—Myalgia—Capecitabine—colon cancer	0.00012	0.00123	CcSEcCtD
Cabazitaxel—Anxiety—Capecitabine—colon cancer	0.00012	0.00123	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00012	0.00122	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Methotrexate—colon cancer	0.000119	0.00122	CcSEcCtD
Cabazitaxel—Discomfort—Capecitabine—colon cancer	0.000119	0.00122	CcSEcCtD
Cabazitaxel—Urethral disorder—Methotrexate—colon cancer	0.000119	0.00121	CcSEcCtD
Cabazitaxel—Diarrhoea—Irinotecan—colon cancer	0.000118	0.00121	CcSEcCtD
Cabazitaxel—Dry mouth—Capecitabine—colon cancer	0.000118	0.0012	CcSEcCtD
Cabazitaxel—Dizziness—Vincristine—colon cancer	0.000117	0.0012	CcSEcCtD
Cabazitaxel—Confusional state—Capecitabine—colon cancer	0.000116	0.00119	CcSEcCtD
Cabazitaxel—Oedema—Capecitabine—colon cancer	0.000115	0.00118	CcSEcCtD
Cabazitaxel—Infection—Capecitabine—colon cancer	0.000115	0.00117	CcSEcCtD
Cabazitaxel—Dizziness—Irinotecan—colon cancer	0.000114	0.00117	CcSEcCtD
Cabazitaxel—Nervous system disorder—Capecitabine—colon cancer	0.000113	0.00116	CcSEcCtD
Cabazitaxel—Eye disorder—Methotrexate—colon cancer	0.000113	0.00116	CcSEcCtD
Cabazitaxel—Diarrhoea—Fluorouracil—colon cancer	0.000113	0.00115	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Capecitabine—colon cancer	0.000113	0.00115	CcSEcCtD
Cabazitaxel—Tinnitus—Methotrexate—colon cancer	0.000113	0.00115	CcSEcCtD
Cabazitaxel—Tachycardia—Capecitabine—colon cancer	0.000113	0.00115	CcSEcCtD
Cabazitaxel—Vomiting—Vincristine—colon cancer	0.000113	0.00115	CcSEcCtD
Cabazitaxel—Cardiac disorder—Methotrexate—colon cancer	0.000112	0.00115	CcSEcCtD
Cabazitaxel—Skin disorder—Capecitabine—colon cancer	0.000112	0.00115	CcSEcCtD
Cabazitaxel—Headache—Vincristine—colon cancer	0.000111	0.00113	CcSEcCtD
Cabazitaxel—Anorexia—Capecitabine—colon cancer	0.00011	0.00112	CcSEcCtD
Cabazitaxel—Angiopathy—Methotrexate—colon cancer	0.00011	0.00112	CcSEcCtD
Cabazitaxel—Vomiting—Irinotecan—colon cancer	0.00011	0.00112	CcSEcCtD
Cabazitaxel—Immune system disorder—Methotrexate—colon cancer	0.000109	0.00112	CcSEcCtD
Cabazitaxel—Dizziness—Fluorouracil—colon cancer	0.000109	0.00112	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Methotrexate—colon cancer	0.000109	0.00111	CcSEcCtD
Cabazitaxel—Chills—Methotrexate—colon cancer	0.000108	0.00111	CcSEcCtD
Cabazitaxel—Headache—Irinotecan—colon cancer	0.000108	0.0011	CcSEcCtD
Cabazitaxel—Hypotension—Capecitabine—colon cancer	0.000108	0.0011	CcSEcCtD
Cabazitaxel—Alopecia—Methotrexate—colon cancer	0.000107	0.00109	CcSEcCtD
Cabazitaxel—Mental disorder—Methotrexate—colon cancer	0.000106	0.00108	CcSEcCtD
Cabazitaxel—ABCB1—liver—colon cancer	0.000106	0.0027	CbGeAlD
Cabazitaxel—Erythema—Methotrexate—colon cancer	0.000105	0.00108	CcSEcCtD
Cabazitaxel—Malnutrition—Methotrexate—colon cancer	0.000105	0.00108	CcSEcCtD
Cabazitaxel—Nausea—Vincristine—colon cancer	0.000105	0.00107	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000105	0.00107	CcSEcCtD
Cabazitaxel—Vomiting—Fluorouracil—colon cancer	0.000105	0.00107	CcSEcCtD
Cabazitaxel—Paraesthesia—Capecitabine—colon cancer	0.000104	0.00106	CcSEcCtD
Cabazitaxel—Headache—Fluorouracil—colon cancer	0.000103	0.00106	CcSEcCtD
Cabazitaxel—Dysgeusia—Methotrexate—colon cancer	0.000103	0.00105	CcSEcCtD
Cabazitaxel—Dyspnoea—Capecitabine—colon cancer	0.000103	0.00105	CcSEcCtD
Cabazitaxel—Nausea—Irinotecan—colon cancer	0.000102	0.00105	CcSEcCtD
Cabazitaxel—Back pain—Methotrexate—colon cancer	0.000102	0.00104	CcSEcCtD
Cabazitaxel—Dyspepsia—Capecitabine—colon cancer	0.000102	0.00104	CcSEcCtD
Cabazitaxel—Decreased appetite—Capecitabine—colon cancer	0.0001	0.00103	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Capecitabine—colon cancer	9.96e-05	0.00102	CcSEcCtD
Cabazitaxel—Fatigue—Capecitabine—colon cancer	9.95e-05	0.00102	CcSEcCtD
Cabazitaxel—Constipation—Capecitabine—colon cancer	9.87e-05	0.00101	CcSEcCtD
Cabazitaxel—Pain—Capecitabine—colon cancer	9.87e-05	0.00101	CcSEcCtD
Cabazitaxel—Nausea—Fluorouracil—colon cancer	9.81e-05	0.001	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Methotrexate—colon cancer	9.77e-05	0.000998	CcSEcCtD
Cabazitaxel—Anaemia—Methotrexate—colon cancer	9.73e-05	0.000994	CcSEcCtD
Cabazitaxel—Feeling abnormal—Capecitabine—colon cancer	9.51e-05	0.000972	CcSEcCtD
Cabazitaxel—Malaise—Methotrexate—colon cancer	9.49e-05	0.00097	CcSEcCtD
Cabazitaxel—Vertigo—Methotrexate—colon cancer	9.46e-05	0.000967	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Capecitabine—colon cancer	9.44e-05	0.000965	CcSEcCtD
Cabazitaxel—Leukopenia—Methotrexate—colon cancer	9.42e-05	0.000963	CcSEcCtD
Cabazitaxel—Cough—Methotrexate—colon cancer	9.18e-05	0.000939	CcSEcCtD
Cabazitaxel—Body temperature increased—Capecitabine—colon cancer	9.12e-05	0.000933	CcSEcCtD
Cabazitaxel—Abdominal pain—Capecitabine—colon cancer	9.12e-05	0.000933	CcSEcCtD
Cabazitaxel—Chest pain—Methotrexate—colon cancer	8.96e-05	0.000916	CcSEcCtD
Cabazitaxel—Arthralgia—Methotrexate—colon cancer	8.96e-05	0.000916	CcSEcCtD
Cabazitaxel—Myalgia—Methotrexate—colon cancer	8.96e-05	0.000916	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	8.9e-05	0.00091	CcSEcCtD
Cabazitaxel—Discomfort—Methotrexate—colon cancer	8.85e-05	0.000905	CcSEcCtD
Cabazitaxel—Confusional state—Methotrexate—colon cancer	8.66e-05	0.000885	CcSEcCtD
Cabazitaxel—Infection—Methotrexate—colon cancer	8.53e-05	0.000872	CcSEcCtD
Cabazitaxel—Hypersensitivity—Capecitabine—colon cancer	8.5e-05	0.000869	CcSEcCtD
Cabazitaxel—Nervous system disorder—Methotrexate—colon cancer	8.42e-05	0.000861	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Methotrexate—colon cancer	8.41e-05	0.00086	CcSEcCtD
Cabazitaxel—Skin disorder—Methotrexate—colon cancer	8.34e-05	0.000853	CcSEcCtD
Cabazitaxel—Asthenia—Capecitabine—colon cancer	8.28e-05	0.000846	CcSEcCtD
Cabazitaxel—Anorexia—Methotrexate—colon cancer	8.19e-05	0.000837	CcSEcCtD
Cabazitaxel—ABCB1—lymph node—colon cancer	8.1e-05	0.00207	CbGeAlD
Cabazitaxel—Hypotension—Methotrexate—colon cancer	8.03e-05	0.000821	CcSEcCtD
Cabazitaxel—Diarrhoea—Capecitabine—colon cancer	7.89e-05	0.000807	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Methotrexate—colon cancer	7.83e-05	0.0008	CcSEcCtD
Cabazitaxel—Paraesthesia—Methotrexate—colon cancer	7.71e-05	0.000789	CcSEcCtD
Cabazitaxel—Dyspnoea—Methotrexate—colon cancer	7.66e-05	0.000783	CcSEcCtD
Cabazitaxel—Dizziness—Capecitabine—colon cancer	7.63e-05	0.00078	CcSEcCtD
Cabazitaxel—Dyspepsia—Methotrexate—colon cancer	7.56e-05	0.000773	CcSEcCtD
Cabazitaxel—Decreased appetite—Methotrexate—colon cancer	7.47e-05	0.000763	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Methotrexate—colon cancer	7.42e-05	0.000758	CcSEcCtD
Cabazitaxel—Fatigue—Methotrexate—colon cancer	7.41e-05	0.000757	CcSEcCtD
Cabazitaxel—Pain—Methotrexate—colon cancer	7.35e-05	0.000751	CcSEcCtD
Cabazitaxel—Vomiting—Capecitabine—colon cancer	7.34e-05	0.00075	CcSEcCtD
Cabazitaxel—TUBB1—Pathogenic Escherichia coli infection—CTNNB1—colon cancer	7.27e-05	0.00748	CbGpPWpGaD
Cabazitaxel—Headache—Capecitabine—colon cancer	7.23e-05	0.000739	CcSEcCtD
Cabazitaxel—Feeling abnormal—Methotrexate—colon cancer	7.08e-05	0.000724	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Methotrexate—colon cancer	7.02e-05	0.000718	CcSEcCtD
Cabazitaxel—Nausea—Capecitabine—colon cancer	6.85e-05	0.000701	CcSEcCtD
Cabazitaxel—Abdominal pain—Methotrexate—colon cancer	6.79e-05	0.000694	CcSEcCtD
Cabazitaxel—Body temperature increased—Methotrexate—colon cancer	6.79e-05	0.000694	CcSEcCtD
Cabazitaxel—TUBB4B—Cell Cycle—MLH3—colon cancer	6.67e-05	0.00687	CbGpPWpGaD
Cabazitaxel—TUBB4A—Pathogenic Escherichia coli infection—CTNNB1—colon cancer	6.52e-05	0.00672	CbGpPWpGaD
Cabazitaxel—TUBB2A—Signaling events mediated by HDAC Class III—TP53—colon cancer	6.51e-05	0.0067	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metapathway biotransformation—CHST5—colon cancer	6.37e-05	0.00656	CbGpPWpGaD
Cabazitaxel—Hypersensitivity—Methotrexate—colon cancer	6.33e-05	0.000647	CcSEcCtD
Cabazitaxel—TUBA4A—Metabolism of proteins—CDX2—colon cancer	6.27e-05	0.00645	CbGpPWpGaD
Cabazitaxel—Asthenia—Methotrexate—colon cancer	6.16e-05	0.00063	CcSEcCtD
Cabazitaxel—TUBA4A—Platelet degranulation—VEGFA—colon cancer	6.04e-05	0.00622	CbGpPWpGaD
Cabazitaxel—TUBB4B—Pathogenic Escherichia coli infection—CTNNB1—colon cancer	5.97e-05	0.00615	CbGpPWpGaD
Cabazitaxel—ABCG2—HIF-1-alpha transcription factor network—ABCB1—colon cancer	5.92e-05	0.0061	CbGpPWpGaD
Cabazitaxel—Diarrhoea—Methotrexate—colon cancer	5.88e-05	0.000601	CcSEcCtD
Cabazitaxel—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	5.84e-05	0.00601	CbGpPWpGaD
Cabazitaxel—TUBA4A—Response to elevated platelet cytosolic Ca2+—VEGFA—colon cancer	5.75e-05	0.00593	CbGpPWpGaD
Cabazitaxel—Dizziness—Methotrexate—colon cancer	5.68e-05	0.000581	CcSEcCtD
Cabazitaxel—TUBA4A—Platelet degranulation—TGFB1—colon cancer	5.54e-05	0.00571	CbGpPWpGaD
Cabazitaxel—Vomiting—Methotrexate—colon cancer	5.46e-05	0.000558	CcSEcCtD
Cabazitaxel—Headache—Methotrexate—colon cancer	5.38e-05	0.00055	CcSEcCtD
Cabazitaxel—TUBB6—Metabolism of proteins—CDX2—colon cancer	5.38e-05	0.00554	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—CDX2—colon cancer	5.38e-05	0.00554	CbGpPWpGaD
Cabazitaxel—TUBA4A—Metabolism of proteins—MUC2—colon cancer	5.33e-05	0.00549	CbGpPWpGaD
Cabazitaxel—TUBA4A—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	5.28e-05	0.00544	CbGpPWpGaD
Cabazitaxel—TUBB3—Metabolism of proteins—CDX2—colon cancer	5.19e-05	0.00535	CbGpPWpGaD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—HNF4A—colon cancer	5.13e-05	0.00528	CbGpPWpGaD
Cabazitaxel—Nausea—Methotrexate—colon cancer	5.1e-05	0.000522	CcSEcCtD
Cabazitaxel—TUBB2A—Metabolism of proteins—CDX2—colon cancer	5.03e-05	0.00518	CbGpPWpGaD
Cabazitaxel—TUBB1—Metabolism of proteins—CDX2—colon cancer	4.92e-05	0.00506	CbGpPWpGaD
Cabazitaxel—CYP3A4—Irinotecan Pathway—APC—colon cancer	4.91e-05	0.00506	CbGpPWpGaD
Cabazitaxel—TUBA4A—G2/M Transition—EP300—colon cancer	4.84e-05	0.00498	CbGpPWpGaD
Cabazitaxel—TUBA4A—Mitotic G2-G2/M phases—EP300—colon cancer	4.77e-05	0.00491	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—CA7—colon cancer	4.72e-05	0.00487	CbGpPWpGaD
Cabazitaxel—ABCG2—HIF-2-alpha transcription factor network—EP300—colon cancer	4.58e-05	0.00472	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—MUC2—colon cancer	4.57e-05	0.00471	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—MUC2—colon cancer	4.57e-05	0.00471	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—MLH1—colon cancer	4.55e-05	0.00469	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—CDX2—colon cancer	4.42e-05	0.00455	CbGpPWpGaD
Cabazitaxel—TUBB3—Metabolism of proteins—MUC2—colon cancer	4.42e-05	0.00455	CbGpPWpGaD
Cabazitaxel—ABCG2—HIF-2-alpha transcription factor network—VEGFA—colon cancer	4.34e-05	0.00447	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—BUB1B—colon cancer	4.33e-05	0.00446	CbGpPWpGaD
Cabazitaxel—TUBB2A—Metabolism of proteins—MUC2—colon cancer	4.28e-05	0.0044	CbGpPWpGaD
Cabazitaxel—TUBB1—Metabolism of proteins—MUC2—colon cancer	4.18e-05	0.00431	CbGpPWpGaD
Cabazitaxel—TUBB—G2/M Transition—EP300—colon cancer	4.11e-05	0.00424	CbGpPWpGaD
Cabazitaxel—TUBB—Mitotic G2-G2/M phases—EP300—colon cancer	4.06e-05	0.00418	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—CDX2—colon cancer	4.04e-05	0.00416	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—BUB1B—colon cancer	3.87e-05	0.00399	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—MLH1—colon cancer	3.87e-05	0.00399	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	3.82e-05	0.00393	CbGpPWpGaD
Cabazitaxel—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	3.78e-05	0.0039	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—MUC2—colon cancer	3.75e-05	0.00387	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—BUB1B—colon cancer	3.68e-05	0.00379	CbGpPWpGaD
Cabazitaxel—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	3.52e-05	0.00362	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—MUC2—colon cancer	3.43e-05	0.00354	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	3.42e-05	0.00352	CbGpPWpGaD
Cabazitaxel—TUBB4A—G2/M Transition—EP300—colon cancer	3.41e-05	0.00351	CbGpPWpGaD
Cabazitaxel—TUBB4A—Mitotic G2-G2/M phases—EP300—colon cancer	3.36e-05	0.00346	CbGpPWpGaD
Cabazitaxel—ABCG2—Fluoropyrimidine Activity—TP53—colon cancer	3.36e-05	0.00346	CbGpPWpGaD
Cabazitaxel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	3.35e-05	0.00345	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—TYMS—colon cancer	3.32e-05	0.00342	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—BUB1B—colon cancer	3.29e-05	0.00339	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—MLH1—colon cancer	3.21e-05	0.00331	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CA7—colon cancer	3.17e-05	0.00327	CbGpPWpGaD
Cabazitaxel—TUBB4B—G2/M Transition—EP300—colon cancer	3.12e-05	0.00321	CbGpPWpGaD
Cabazitaxel—TUBB4B—Mitotic G2-G2/M phases—EP300—colon cancer	3.07e-05	0.00317	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—BUB1B—colon cancer	3.05e-05	0.00314	CbGpPWpGaD
Cabazitaxel—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	2.98e-05	0.00307	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—TYMS—colon cancer	2.97e-05	0.00306	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CA7—colon cancer	2.94e-05	0.00303	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—MLH1—colon cancer	2.93e-05	0.00302	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—CHST5—colon cancer	2.86e-05	0.00295	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—ODC1—colon cancer	2.86e-05	0.00295	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—TYMS—colon cancer	2.82e-05	0.00291	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—BUB1B—colon cancer	2.79e-05	0.00287	CbGpPWpGaD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—SRC—colon cancer	2.75e-05	0.00283	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—BUB1B—colon cancer	2.73e-05	0.00281	CbGpPWpGaD
Cabazitaxel—ABCG2—HIF-1-alpha transcription factor network—EP300—colon cancer	2.69e-05	0.00278	CbGpPWpGaD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—VEGFA—colon cancer	2.68e-05	0.00276	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	2.6e-05	0.00268	CbGpPWpGaD
Cabazitaxel—ABCG2—HIF-1-alpha transcription factor network—VEGFA—colon cancer	2.55e-05	0.00263	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—TYMS—colon cancer	2.52e-05	0.0026	CbGpPWpGaD
Cabazitaxel—CYP2C8—Arachidonic acid metabolism—PTGS2—colon cancer	2.51e-05	0.00259	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—BUB1B—colon cancer	2.5e-05	0.00257	CbGpPWpGaD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—TGFB1—colon cancer	2.46e-05	0.00253	CbGpPWpGaD
Cabazitaxel—TUBB6—Transmembrane transport of small molecules—ABCB1—colon cancer	2.38e-05	0.00245	CbGpPWpGaD
Cabazitaxel—TUBB2B—Transmembrane transport of small molecules—ABCB1—colon cancer	2.38e-05	0.00245	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—TYMS—colon cancer	2.34e-05	0.00241	CbGpPWpGaD
Cabazitaxel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	2.33e-05	0.0024	CbGpPWpGaD
Cabazitaxel—TUBB3—Transmembrane transport of small molecules—ABCB1—colon cancer	2.3e-05	0.00237	CbGpPWpGaD
Cabazitaxel—TUBB2A—Transmembrane transport of small molecules—ABCB1—colon cancer	2.23e-05	0.00229	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	2.19e-05	0.00226	CbGpPWpGaD
Cabazitaxel—TUBB1—Transmembrane transport of small molecules—ABCB1—colon cancer	2.18e-05	0.00224	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—TYMS—colon cancer	2.14e-05	0.0022	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CA7—colon cancer	2.11e-05	0.00217	CbGpPWpGaD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	2.09e-05	0.00216	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—TYMS—colon cancer	2.09e-05	0.00215	CbGpPWpGaD
Cabazitaxel—TUBB4A—Transmembrane transport of small molecules—ABCB1—colon cancer	1.95e-05	0.00201	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—ODC1—colon cancer	1.92e-05	0.00198	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CHST5—colon cancer	1.92e-05	0.00198	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—TYMS—colon cancer	1.91e-05	0.00197	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CA7—colon cancer	1.82e-05	0.00188	CbGpPWpGaD
Cabazitaxel—TUBB4B—Transmembrane transport of small molecules—ABCB1—colon cancer	1.79e-05	0.00184	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CHST5—colon cancer	1.78e-05	0.00183	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—ODC1—colon cancer	1.78e-05	0.00183	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	1.75e-05	0.0018	CbGpPWpGaD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—AKT1—colon cancer	1.71e-05	0.00176	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—CCND1—colon cancer	1.67e-05	0.00172	CbGpPWpGaD
Cabazitaxel—ABCG2—HIF-1-alpha transcription factor network—AKT1—colon cancer	1.63e-05	0.00168	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—CDKN1A—colon cancer	1.62e-05	0.00167	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Transmembrane transport of small molecules—ABCB1—colon cancer	1.61e-05	0.00166	CbGpPWpGaD
Cabazitaxel—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	1.61e-05	0.00166	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CA7—colon cancer	1.59e-05	0.00164	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—EP300—colon cancer	1.54e-05	0.00159	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—CCND1—colon cancer	1.5e-05	0.00154	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—EP300—colon cancer	1.46e-05	0.0015	CbGpPWpGaD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	1.46e-05	0.0015	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—CDKN1A—colon cancer	1.45e-05	0.00149	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—CCND1—colon cancer	1.42e-05	0.00146	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—SRC—colon cancer	1.42e-05	0.00146	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—CASP3—colon cancer	1.41e-05	0.00145	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—VEGFA—colon cancer	1.38e-05	0.00142	CbGpPWpGaD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	1.38e-05	0.00142	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—EP300—colon cancer	1.38e-05	0.00142	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—CDKN1A—colon cancer	1.38e-05	0.00142	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—NRAS—colon cancer	1.36e-05	0.00141	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	1.34e-05	0.00138	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—MYC—colon cancer	1.34e-05	0.00138	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—EP300—colon cancer	1.31e-05	0.00135	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	1.29e-05	0.00133	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ODC1—colon cancer	1.28e-05	0.00131	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CHST5—colon cancer	1.28e-05	0.00131	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—CCND1—colon cancer	1.27e-05	0.00131	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—TGFB1—colon cancer	1.27e-05	0.00131	CbGpPWpGaD
Cabazitaxel—TUBA4A—Metabolism of proteins—CTNNB1—colon cancer	1.23e-05	0.00127	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—CDKN1A—colon cancer	1.23e-05	0.00127	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—MYC—colon cancer	1.2e-05	0.00124	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—VEGFA—colon cancer	1.19e-05	0.00123	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.18e-05	0.00122	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—CCND1—colon cancer	1.18e-05	0.00121	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—KRAS—colon cancer	1.17e-05	0.00121	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—EP300—colon cancer	1.17e-05	0.00121	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—MYC—colon cancer	1.14e-05	0.00117	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—CDKN1A—colon cancer	1.14e-05	0.00117	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ODC1—colon cancer	1.1e-05	0.00114	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CHST5—colon cancer	1.1e-05	0.00114	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—TGFB1—colon cancer	1.1e-05	0.00113	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—ABCB1—colon cancer	1.08e-05	0.00112	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—EP300—colon cancer	1.08e-05	0.00112	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—PIK3CA—colon cancer	1.08e-05	0.00111	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—CCND1—colon cancer	1.08e-05	0.00111	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—CTNNB1—colon cancer	1.06e-05	0.00109	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—CTNNB1—colon cancer	1.06e-05	0.00109	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—CCND1—colon cancer	1.05e-05	0.00108	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—TP53—colon cancer	1.04e-05	0.00107	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—CDKN1A—colon cancer	1.04e-05	0.00107	CbGpPWpGaD
Cabazitaxel—TUBB3—Metabolism of proteins—CTNNB1—colon cancer	1.02e-05	0.00105	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—MYC—colon cancer	1.02e-05	0.00105	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—CDKN1A—colon cancer	1.02e-05	0.00105	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—ABCB1—colon cancer	1e-05	0.00103	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—HRAS—colon cancer	9.98e-06	0.00103	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—EP300—colon cancer	9.92e-06	0.00102	CbGpPWpGaD
Cabazitaxel—TUBB2A—Metabolism of proteins—CTNNB1—colon cancer	9.9e-06	0.00102	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	9.86e-06	0.00102	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—TP53—colon cancer	9.85e-06	0.00101	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CA7—colon cancer	9.79e-06	0.00101	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—EP300—colon cancer	9.7e-06	0.000999	CbGpPWpGaD
Cabazitaxel—TUBB1—Metabolism of proteins—CTNNB1—colon cancer	9.68e-06	0.000997	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—CCND1—colon cancer	9.63e-06	0.000992	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ODC1—colon cancer	9.62e-06	0.000991	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CHST5—colon cancer	9.62e-06	0.000991	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—MYC—colon cancer	9.45e-06	0.000973	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—CDKN1A—colon cancer	9.32e-06	0.00096	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	9.29e-06	0.000957	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—EP300—colon cancer	8.87e-06	0.000913	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—AKT1—colon cancer	8.81e-06	0.000908	CbGpPWpGaD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	8.8e-06	0.000907	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—CTNNB1—colon cancer	8.69e-06	0.000896	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—MYC—colon cancer	8.64e-06	0.00089	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—MYC—colon cancer	8.45e-06	0.00087	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—TP53—colon cancer	8.37e-06	0.000863	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—CTNNB1—colon cancer	7.95e-06	0.000819	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	7.94e-06	0.000818	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—colon cancer	7.73e-06	0.000796	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—MYC—colon cancer	7.73e-06	0.000796	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—ABCB1—colon cancer	7.56e-06	0.000779	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	7.49e-06	0.000771	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—TYMS—colon cancer	7.43e-06	0.000765	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	6.95e-06	0.000716	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—TP53—colon cancer	6.94e-06	0.000715	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	6.76e-06	0.000697	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	6.7e-06	0.00069	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	6.54e-06	0.000674	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—TP53—colon cancer	6.35e-06	0.000654	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	6.24e-06	0.000643	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	6.23e-06	0.000641	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	6.05e-06	0.000624	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CHST5—colon cancer	5.93e-06	0.000611	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ODC1—colon cancer	5.93e-06	0.000611	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	5.9e-06	0.000607	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.72e-06	0.000589	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	5.42e-06	0.000559	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	5.41e-06	0.000557	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	5.31e-06	0.000547	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PPARG—colon cancer	5.26e-06	0.000542	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.19e-06	0.000535	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—ABCB1—colon cancer	5.08e-06	0.000523	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	5.01e-06	0.000516	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—TYMS—colon cancer	4.99e-06	0.000514	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—ABCB1—colon cancer	4.7e-06	0.000485	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—TYMS—colon cancer	4.62e-06	0.000476	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	4.61e-06	0.000474	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.56e-06	0.00047	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	4.46e-06	0.000459	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PTGS2—colon cancer	4.14e-06	0.000426	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.84e-06	0.000396	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	3.76e-06	0.000388	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.59e-06	0.00037	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PPARG—colon cancer	3.53e-06	0.000364	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—EP300—colon cancer	3.44e-06	0.000355	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ABCB1—colon cancer	3.37e-06	0.000347	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—TYMS—colon cancer	3.31e-06	0.000341	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PPARG—colon cancer	3.27e-06	0.000337	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.98e-06	0.000307	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ABCB1—colon cancer	2.92e-06	0.000301	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—TYMS—colon cancer	2.87e-06	0.000295	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PTGS2—colon cancer	2.78e-06	0.000286	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PTGS2—colon cancer	2.57e-06	0.000265	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PIK3CA—colon cancer	2.55e-06	0.000262	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—TYMS—colon cancer	2.5e-06	0.000257	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PPARG—colon cancer	2.34e-06	0.000242	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—EP300—colon cancer	2.31e-06	0.000238	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.21e-06	0.000227	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—EP300—colon cancer	2.14e-06	0.000221	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—AKT1—colon cancer	2.08e-06	0.000214	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PPARG—colon cancer	2.03e-06	0.000209	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PTGS2—colon cancer	1.84e-06	0.00019	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PPARG—colon cancer	1.77e-06	0.000182	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PIK3CA—colon cancer	1.71e-06	0.000176	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PTGS2—colon cancer	1.6e-06	0.000165	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PIK3CA—colon cancer	1.58e-06	0.000163	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ABCB1—colon cancer	1.57e-06	0.000161	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—TYMS—colon cancer	1.54e-06	0.000159	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—EP300—colon cancer	1.53e-06	0.000158	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—AKT1—colon cancer	1.4e-06	0.000144	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PTGS2—colon cancer	1.39e-06	0.000143	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—EP300—colon cancer	1.33e-06	0.000137	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—AKT1—colon cancer	1.29e-06	0.000133	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—EP300—colon cancer	1.16e-06	0.000119	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PIK3CA—colon cancer	1.13e-06	0.000117	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PPARG—colon cancer	1.09e-06	0.000112	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PIK3CA—colon cancer	9.83e-07	0.000101	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—AKT1—colon cancer	9.27e-07	9.55e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PTGS2—colon cancer	8.58e-07	8.83e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PIK3CA—colon cancer	8.56e-07	8.82e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—AKT1—colon cancer	8.03e-07	8.27e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—EP300—colon cancer	7.13e-07	7.35e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—AKT1—colon cancer	7e-07	7.21e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PIK3CA—colon cancer	5.28e-07	5.43e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—AKT1—colon cancer	4.31e-07	4.44e-05	CbGpPWpGaD
